Henry Schein Reports Strong Q4 & Full-Year 2025 Results, Exceeding Guidance; Initiates Positive 2026 Outlook & $850M Share Buyback

summarizeSummary

Henry Schein reported strong Q4 and full-year 2025 financial results, exceeding guidance, and provided positive 2026 financial guidance, alongside a significant $850 million share repurchase program for 2025.

check_boxKey Events

• Exceeded Q4 2025 Financial Guidance

  Henry Schein reported Q4 2025 non-GAAP diluted EPS of $1.34, surpassing its increased guidance, driven by 7.7% total net sales growth (4.9% internal), marking the highest sales growth in 15 quarters.

• Introduced Positive 2026 Financial Guidance

  The company expects 2026 non-GAAP diluted EPS to be in the range of $5.23 to $5.37, with total sales growth projected at 3-5% over 2025, indicating continued momentum.

• Executed Substantial Share Repurchase Program

  For the full year 2025, Henry Schein repurchased approximately $850 million of common stock, including $200 million in Q4, demonstrating a significant return of capital to shareholders. $780 million remains authorized for future repurchases.

• Strategic Plan Execution & CEO Transition

  Management highlighted the effective execution of its 2025-2027 BOLD+1 strategic plan as a driver for growth and reiterated the upcoming arrival of Fred Lowery as CEO next week, following the January 12, 2026 announcement.

auto_awesomeAnalysis

This 8-K is highly positive, showcasing Henry Schein's robust financial performance and optimistic outlook. The company not only exceeded its increased Q4 2025 guidance with strong sales growth across all businesses, but also provided solid 2026 guidance, projecting continued EPS and sales growth. The substantial $850 million in share repurchases for 2025, including $200 million in Q4, underscores management's confidence in the company's valuation and commitment to shareholder returns. This strong operational and financial execution, coupled with the smooth transition to a new CEO as previously announced, suggests a healthy trajectory for Henry Schein. Investors should view this filing as a strong affirmation of the company's strategic direction and financial stability.